Results 161 to 170 of about 8,708 (251)

Cost-effectiveness of ceftolozane/tazobactam compared to meropenem in ventilator-associated pneumonia. [PDF]

Cost Eff Resour Alloc
Buendía JA, Patiño DG, Zuluaga Salazar AF.   +2 more
europepmc   +1 more source

Raising the Bar of PK/PD Target Attainment of Beta-Lactams in Daily Clinical Practice: An Effective Strategy to Overcome Resistance Development to Novel Beta-Lactams? [PDF]

Infect Dis Rep
Gatti M, Pea F.
europepmc   +1 more source

Landscape of resistance to ceftolozane/tazobactam and ceftazidime/avibactam in strains of Pseudomonas aeruginosa: a genomic approach in strains without selection pressure in a tertiary-care paediatric hospital in Mexico. [PDF]

BMC Infect Dis
A Méndez HE, Merida-Vieyra J, Aparicio-Ozores G, Hernández-Durán M, Méndez-Tenorio A, Tapia-Reyes A, Bautista-Hernandez R, Juárez-Hinojos D, Aquino-Andrade A.   +8 more
europepmc   +1 more source

Pharmacokinetic/Pharmacodynamic of ceftolozane/tazobactam in critically ill patients receiving extracorporeal membrane oxygenation (ECMO): a retrospective cohort analysis. [PDF]

Crit Care
Coppens A, Gautier M, Zahr N, Junot H, Rached B, Levy D, Saura O, Chommeloux J, Hekimian G, Schmidt M, Combes A, Bleibtreu A, Luyt CE.   +12 more
europepmc   +1 more source

Cryptic Binding Pockets in PDC‑3 β‑Lactamase Modulate Resistance Profiles. [PDF]

JACS Au
Chen S, Attana F, Hujer AM, Bethel CR, Taracila MA, Bonomo RA, Haider S.   +6 more
europepmc   +1 more source

Effectiveness of imipenem-relebactam for multidrug-resistant <i>Pseudomonas aeruginosa</i> in pneumonia and bloodstream infections in the United States (MIRAGE). [PDF]

Antimicrob Agents Chemother
Wangchinda W, Wu JY, Abbo LM, Ackley R, Bartley P, Gilboa M, Harrington J, Jaffa R, Klatt ME, Kline EG, Kubat RC, Lepak AJ, McCreary EK, Miller WR, Pearson JC, Shah S, Tran TT, Vega A, Vendetti M, Yucel E, Pogue JM, Shields RK.   +21 more
europepmc   +1 more source

Insights into <i>Klebsiella pneumoniae</i> carbapenem resistance-a two-year retrospective study from a Romanian tertiary care hospital. [PDF]

Front Microbiol
Tălăpan D, Dan MO, Cireşă A, Rafila A.   +3 more
europepmc   +1 more source

New antibiotics for bad bugs: where are we? [PDF]

core   +1 more source

Ceftazidime-Induced Overexpression of MexJK-OprM Confers Resistance to Ceftolozane/Tazobactam in an Isolate of <i>Pseudomonas aeruginosa</i>. [PDF]

Infect Drug Resist
Sato T, Tamura M, Kaimori K, Okumura F, Ikejima S, Nakai H, Kawamura M, Fujimura S.   +7 more
europepmc   +1 more source

Erratum: Ceftolozane-tazobactam in nosocomial pneumonia

, 2022
FJ, Candel, J, González Del Castillo, A, Julián Jiménez, M, Matesanz   +3 more
openaire   +1 more source